When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Merck's Keytruda gets FDA nod for expanded use in lung cancer

   www.aol.com/news/mercks-keytruda-gets-u-fdas...

   The U.S. health regulator's approval extends Keytruda's use in combination with chemotherapy as a treatment given before surgery to shrink the size of the tumor in patients. The U.S. drugmaker is ...

3. Pembrolizumab - Wikipedia

   en.wikipedia.org/wiki/Pembrolizumab

   Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.

4. Merck's Keytruda combo gets FDA nod for expanded use in ... - AOL

   www.aol.com/news/mercks-keytruda-combo-gets-fda...

   Merck's top-selling drug Keytruda helps the body's own immune system fend off cancer by blocking a protein called PD-1. It has been approved to treat more than ten kinds of cancer.

5. Merck's Keytruda Secures First FDA-Approval For Rare Form ...

   www.aol.com/mercks-keytruda-secures-first-fda...

   Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...

6. Merck's Experimental Favezelimab/Keytruda Combo Fails ... - AOL

   www.aol.com/mercks-experimental-favezelimab...

   Concurrently, on Wednesday, Japan’s drug regulator approved new indications for Keytruda (pembrolizumab), in certain lung and urothelial cancers. Merck Stock Prediction For 2024

7. Merck's Keytruda combo succeeds in late-stage trial for ... - AOL

   www.aol.com/news/mercks-keytruda-combo-succeeds...

   The January approval was based on a late-stage study where the drug combination reduced the risk of cancer progression or death but had not shown clinically meaningful improvement in overall ...